Literature DB >> 1373258

Palliative care and melanoma: the care of the patient with progressive disease.

J N Lickiss1.   

Abstract

The World Health Organization has taken the lead in recent years in encouraging an appropriate focus on palliative care which includes but goes beyond terminal care. Comprehensive care of patients with advanced progressive disease requires increased emphasis, with adequate resources. Management of major symptoms is a crucial component of such a care program and requires the application of recent advances in palliative therapeutics (notably but not only good quality pain management), whether or not direct antitumor strategies are being continued. The choice of treatment approaches must be related to the patient's personal priorities.

Entities:  

Mesh:

Year:  1992        PMID: 1373258     DOI: 10.1007/bf02071533

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

Review 1.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

2.  I.v. infusion of opioids for cancer pain: clinical review and guidelines for use.

Authors:  R K Portenoy; D E Moulin; A Rogers; C E Inturrisi; K M Foley
Journal:  Cancer Treat Rep       Date:  1986-05

Review 3.  Pharmacological treatment of neuralgic and neuropathic pain.

Authors:  H J McQuay
Journal:  Cancer Surv       Date:  1988

Review 4.  Controversies in cancer pain. Medical perspectives.

Authors:  K M Foley
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

Review 5.  Neurologic pain syndromes in patients with cancer.

Authors:  K Elliott; K M Foley
Journal:  Crit Care Clin       Date:  1990-04       Impact factor: 3.598

6.  The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects.

Authors:  R F Kaiko; R P Grandy; B Oshlack; J Pav; J Horodniak; G Thomas; E Ingber; P D Goldenheim
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

7.  The nature of suffering and the goals of medicine.

Authors:  E J Cassel
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

Review 8.  WHO cancer pain relief programme.

Authors:  J Stjernswärd
Journal:  Cancer Surv       Date:  1988

Review 9.  The pharmacological treatment of bone pain.

Authors:  G W Hanks
Journal:  Cancer Surv       Date:  1988
  9 in total
  1 in total

Review 1.  The aging oesophagus.

Authors:  J Tack; G Vantrappen
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.